Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Waldencast plc - Class A Ordinary Share (NQ:WALD)

2.110 -0.020 (-0.94%)
Streaming Delayed Price Updated: 11:22 AM EDT, Oct 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,486
Open 2.120
Bid (Size) 2.100 (2)
Ask (Size) 2.130 (6)
Prev. Close 2.130
Today's Range 2.000 - 2.120
52wk Range 1.480 - 4.180
Shares Outstanding 9,342,874
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum
A Next-Generation, Redensifying Scalp Serum Clinically Proven to Promote Fuller, Denser-Looking Hair* 
From Waldencast plc
Via GlobeNewswire
Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand
U.S. Launch Planned in 2026 and Positions Obagi Medical as a Leading Dermatological Megabrand at the Convergence of Integrated Skincare and Aesthetics While Doubling its Addressable Market 
From Waldencast plc
Via GlobeNewswire

Performance

YTD
-43.6%
-43.6%
1 Month
+15.3%
+15.3%
3 Month
-18.2%
-18.2%
6 Month
-20.1%
-20.1%
1 Year
-38.7%
-38.7%

More News

Read More
Why Palo Alto Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation
From Waldencast plc
Via GlobeNewswire
Curious about the stocks that are showing activity after the closing bell on Monday?
Via Chartmill
Earnings Scheduled For August 18, 2025
Via Benzinga
Waldencast Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Via Benzinga
Gore Range Capital Announces Sale of Novaestiq Corp. to Waldencast
Via ACCESS Newswire
Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand
From Waldencast plc
Via GlobeNewswire
Altimmune, Bit Digital, Kratos Defense & Security Solutions And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
Waldencast Reports Q1 2025 Financial Results
From Waldencast plc.
Via GlobeNewswire
Waldencast plc Announces First Quarter Fiscal 2025 Results Conference Call and Webcast
From Waldencast plc.
Via GlobeNewswire
Waldencast Q1 Preview: Beauty Brand Glow Dims On Soft Margins, Flat Sales
Via Benzinga
Topics Earnings
Obagi Medical Announces the Launch of Retinol + PHA Refining Night Cream
From Waldencast plc.
Via GlobeNewswire
Waldencast Reports Q4 2024 and Fiscal Year 2024 Financial Results
From Waldencast plc.
Via GlobeNewswire
Earnings Scheduled For March 18, 2025
Via Benzinga
Waldencast plc Announces Fourth Quarter and Fiscal Year 2024 Results Conference Call and Webcast
From Waldencast plc.
Via GlobeNewswire
Waldencast Q4 Earnings Preview: All Eyes On Tariff Impact, Obagi Skincare Brand
Via Benzinga
Topics World Trade
Waldencast Announces Participation in the TD Cowen 2nd Annual Glowing Ahead: Beauty & Wellness Summit
From Waldencast plc.
Via GlobeNewswire
Obagi Medical Announces the Launch of Latest Innovations in The SUZANOBAGIMD® Collection
From Waldencast plc.
Via GlobeNewswire
Waldencast plc Announces Upcoming Earnings Release and Conference Call Dates
From Waldencast plc.
Via GlobeNewswire
Waldencast Announces Participation in the 2025 IMCAS World Congress
From Waldencast plc.
Via GlobeNewswire
Waldencast Announces Participation in the ICR Conference 2025
From Waldencast plc.
Via GlobeNewswire
Waldencast Reports Q3 2024 Financial Results
From Waldencast plc.
Via GlobeNewswire
Waldencast plc Announces Third Quarter Fiscal 2024 Results Conference Call and Webcast
From Waldencast plc.
Via GlobeNewswire

Frequently Asked Questions

Is Waldencast plc - Class A Ordinary Share publicly traded?
Yes, Waldencast plc - Class A Ordinary Share is publicly traded.
What exchange does Waldencast plc - Class A Ordinary Share trade on?
Waldencast plc - Class A Ordinary Share trades on the Nasdaq Stock Market
What is the ticker symbol for Waldencast plc - Class A Ordinary Share?
The ticker symbol for Waldencast plc - Class A Ordinary Share is WALD on the Nasdaq Stock Market
What is the current price of Waldencast plc - Class A Ordinary Share?
The current price of Waldencast plc - Class A Ordinary Share is 2.110
When was Waldencast plc - Class A Ordinary Share last traded?
The last trade of Waldencast plc - Class A Ordinary Share was at 10/09/25 11:22 AM ET
What is the market capitalization of Waldencast plc - Class A Ordinary Share?
The market capitalization of Waldencast plc - Class A Ordinary Share is 19.71M
How many shares of Waldencast plc - Class A Ordinary Share are outstanding?
Waldencast plc - Class A Ordinary Share has 20M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.